ArticlePathology oncology research : POR2025
Comprehensive genomic profiling for homologous recombination deficiency guides PARP inhibitor therapy recommendations in ovarian cancer.
Alp Inci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.